GGrantIndex
Sort

64,565 grants matching drug discovery

A transformative drug discovery platform for allosteric kinase inhibitors

$706,093
Nicholas Mark Levinson · University Of Minnesota · R01 · FY2025 · CA

Frontotemporal Dementia Induced Pluripotent Stem Cell Consortium

$706,012
Yadong Huang · J. David Gladstone Institutes · R01 · FY2016 · NS

Origin of Cortical Species-specific Distinctions.

$705,968
Pasko Rakic · Yale University · R01 · FY2016 · DA

Small molecule inhibitory leads against influenza RdRp

$705,833
Thomas Roy Webb · Sri International · R01 · FY2015 · AI

Chemical probes of vulnerable pathways in antibiotic-resistant pathogens

$705,796
Tanya Parish · Access To Advanced Health Institute · R01 · FY2013 · AI

Developing a Novel Causal Discovery Framework to Unveil Individualized Cell-Cell Communication Networks

$705,795
Lujia Chen · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · HG

Early-Stage Preclinical Validation of Carbon Monoxide Prodrugs for Acute Kidney Injury

$705,716
Binghe Wang · Georgia State University · R01 · FY2025 · DK

Novel Technology for Reprocessing Flexible Endoscopes

$705,601
Mohamed E Labib · Novaflux Technologies, Inc. · R44 · FY2008 · DK

Mechanisms of endothelial dysfunction in cerebral malaria and barrier restorative pathways

$705,576
Joseph D Smith · Seattle Children'S Hospital · R01 · FY2024 · AI

Mechanisms of endothelial dysfunction in cerebral malaria and barrier restorative pathways

$705,576
Joseph D Smith · Seattle Children'S Hospital · R01 · FY2023 · AI

Effects of Interferon on primate lentiviruses

$705,573
Theodora Hatziioannou · Rockefeller University · R01 · FY2023 · AI

CAREER: Chemical Theory for the Protein Crystal Folding Problem

$705,521
Michael J Schnieders · University Of Iowa · · FY2018 · MPS

Novel Treatment of Menopausal Hot Flushes with an Extradiol Prodrug

$705,517
Istvan Jozsef Merchenthaler · University Of Maryland Baltimore · R01 · FY2009 · AG

Proteolytic Imaging of Remodeling Myocardium

$705,480
Francis G Spinale · Micro Vide, Llc · R42 · FY2017 · HL

Molecular Regulation of Cardiovascular 7 TM Receptors

$705,383
Robert J Lefkowitz · Duke University · R01 · FY2024 · HL

Targeting GPCRs in amygdalar and cortical neural ensembles to treat pain aversion

$705,382
Gregory Scherrer · Univ Of North Carolina Chapel Hill · R01 · FY2024 · NS

Influence of Opioids on the Brainstem Respiratory Network

$705,247
Donald C Bolser · University Of Florida · R01 · FY2021 · HL

Enzyme Discovery for Natural Product Biosynthesis

$705,233
George Neal Phillips · Rice University · U01 · FY2013 · GM

UCSF Paul Calabresi K12 Career Development Program in Clinical Oncology

$705,060
Emily K Bergsland · University Of California, San Francisco · K12 · FY2024 · CA

Development of GCPII inhibitors for the treatment of age-related cognitive disorders

$704,994
Takashi Tsukamoto · Johns Hopkins University · R01 · FY2021 · AG

Novel lead compound advancement for mitigating halogen-induced mortality and morbidity.

$704,952
Shama Ahmad · University Of Alabama At Birmingham · U01 · FY2025 · ES

Human iPSC-derived atrial cardiomyocytes to model atrial fibrillation in a dish

$704,949
Dawood Darbar · University Of Illinois At Chicago · R01 · FY2021 · HL

Genetic and Clinical Predictors of Response to Warfarin and Novel Anticoagulants

$704,923
Nita A Limdi · University Of Alabama At Birmingham · R01 · FY2014 · HL

Pharmacogenetic discovery in the GRADE comparative effectiveness type 2 diabetes clinical trial

$704,872
Jose Carlos Florez · Massachusetts General Hospital · R01 · FY2021 · DK

Targeting the Genus Leishmania with Small Molecules

$704,821
Scott Edward Schaus · Boston University (Charles River Campus) · R01 · FY2025 · AI